 | MHRA Drug Safety Update November_2023-DSU.pdf (274KB) | 23/11/2023 | Download |
| | Ozempic▼(semaglutide) and Saxenda (liraglutide): vigilance required due to potentially harmful falsified products. Nirmatrelvir, ritonavir (Paxlovid▼): be alert to the risk of drug interactions... | |
| MHRA Drug safety Update October_2023.pdf (275KB) | 23/11/2023 | Download |
| | | |
| MHRA Drug Safety Update September-2023-PDF.pdf (267KB) | 27/09/2023 | Download |
| | Statins: very infrequent reports of myasthenia gravis, Page 2 Fluoroquinolone antibiotics: suicidal thoughts and behaviour | |
| MHRA Drug Safety Update August 2023 DSU.pdf (293KB) | 30/08/2023 | Download |
| | Fluoroquinolone antibiotics: reminder of the risk of disabling and potentially long-lasting or irreversible side effects. Methotrexate: advise patients to take precautions in the sun to avoid ... | |
| MHRADrug safety Update July2023 PDF.pdf (212KB) | 24/07/2023 | Download |
| | Hyoscine hydrobromide patches (Scopoderm 1.5mg Patch or Scopoderm TTS Patch): risk of anticholinergic side effects, including hyperthermia. Codeine linctus: public consultation on the proposal to... | |
| MHRA Drug Safety Update June 2023-DSU-PDF.pdf (325KB) | 28/06/2023 | Download |
| | Calcium chloride, calcium gluconate: potential risk of underdosing with calcium gluconate in severe hyperkalaemia; Non-steroidal anti-inflammatory drugs (NSAIDs): potential risks following prolonged... | |
| MHRA Drug Safety Update May 2023-DSU.pdf (327KB) | 25/05/2023 | Download |
| | Direct-acting oral anticoagulants (DOACs): paediatric formulations; reminder of dose adjustments in patients with renal impairment page 2 :Glucose solutions: recommendations to minimise the risks... | |
| MHRA Drug Safety Update April 2023 DSU.pdf (345KB) | 26/04/2023 | Download |
| | Isotretinoin (Roaccutane▼): new safety measures to be introduced in the coming months, including additional oversight on initiation of treatment for patients under 18 years. Janus kinase (JAK)... | |
| MHRA Drug Safety Update March 2023 PDF.pdf (277KB) | 24/03/2023 | Download |
| | Pholcodine-containing cough and cold medicines: withdrawal from UK market as a precautionary measure. Terlipressin in patients with type 1 hepatorenal syndrome: new recommendations to reduce risks... | |
| MHRA Drug Safety Update February 2023 DSU.pdf (206KB) | 27/02/2023 | Download |
| | This month on page 2 we summarise recent advice relating to COVID-19 vaccines and medicines published since the January 2023 issue of Drug Safety Update. And on page 3, we include recent letters,... | |
| MHRA Drug Safety Update January 2023-DSU-PDF.pdf (255KB) | 26/01/2023 | Download |
| | The monthly newsletter from the Medicines and Healthcare products Regulatory Agency and its independent advisor the Commission on Human Medicines | |
| MHRA Drug Safety Update December 2022 PDF.pdf (223KB) | 15/12/2022 | Download |
| | Valproate: reminder of current Pregnancy Prevention Programme requirements; information on new safety measures to be introduced in the coming months. Valproate: reminder of current Pregnancy... | |
